|
||||||||||||||||||||||||||||||
Table 1B: Corresponding analyses for anti-HLA antibody screening/specification. neg.: negative; pos.: positive; PRA: Panel Reactive Antibodies (%); n.d.: not done; the CDC-based cell tray analysis was performed during the autumnal screening [i.e. once a year in accordance with the guidelines of the European Federation of Immunogenetics (EFI)] using the samples taken in October 2009 and October 2010; *: additionally performed DynaChip analyses in all cases exhibiting negative results in accordance with the screening ELISA. |